Tapewire

Nasdaq · USD

TBPH

Theravance Biopharma, Inc.

Export transactions ↓
Tapewire entity
5037
SEC CIK
0001583107
Parsed reports
533

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202503
Jan 202600
Feb 202600
Mar 202603
Apr 202600
May 202600
Jun 202605
Jul 202603
Aug 202600
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 20, 2026 Filed May 22, 2026 22:25 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 8,670 $16.55 $143,488.50
Disclosure

SEC source: 0001961289-26-000006 · form4-05222026_100506.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 344,953

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 22:06 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
GrantOrdinary Shares 37,500 $0.00 $0.00
Disclosure

SEC source: 0001966698-26-000004 · form4-04032026_100411.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 371,949

Read SEC document
April 01, 2026 Filed Apr 3, 2026 22:03 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
GrantOrdinary Shares 18,750 $0.00 $0.00
Disclosure

SEC source: 0001898490-26-000006 · form4-04032026_100454.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 251,449

Read SEC document
April 01, 2026 Filed Apr 3, 2026 22:10 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GrantOrdinary Shares 75,000 $0.00 $0.00
Disclosure

SEC source: 0001302443-26-000004 · form4-04032026_100419.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,651,094

Read SEC document
April 01, 2026 Filed Apr 3, 2026 22:08 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
GrantOrdinary Shares 37,500 $0.00 $0.00
Disclosure

SEC source: 0001961289-26-000004 · form4-04032026_100414.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 353,623

Read SEC document
March 16, 2026 Filed Mar 18, 2026 22:12 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 7,766 $13.92 $108,073.21
Disclosure

SEC source: 0001898490-26-000004 · form4-03182026_100327.xml · nonDerivative · entry 3

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 232,699

F1 · price: This transaction was executed in multiple trades at prices from $13.755 to $14.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 22:12 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 15,534 $14.00 $217,476.00
Disclosure

SEC source: 0001898490-26-000004 · form4-03182026_100327.xml · nonDerivative · entry 2

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 240,465

Read SEC document
March 16, 2026 Filed Mar 18, 2026 22:12 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 7,767 $13.92 $108,087.90
Disclosure

SEC source: 0001898490-26-000004 · form4-03182026_100327.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 255,999

F1 · price: This transaction was executed in multiple trades at prices from $13.755 to $14.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 20, 2026 Filed Feb 25, 2026 00:38 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
Tax withholdingOrdinary Shares 16,851 $19.66 $331,290.66
Disclosure

SEC source: 0002012524-26-000002 · form4-02252026_120255.xml · nonDerivative · entry 1

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,161

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2026 Filed Feb 25, 2026 00:37 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
Tax withholdingOrdinary Shares 20,833 $19.66 $409,576.78
Disclosure

SEC source: 0001966698-26-000002 · form4-02252026_120202.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 334,449

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2026 Filed Feb 25, 2026 00:35 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
Tax withholdingOrdinary Shares 13,929 $19.66 $273,844.14
Disclosure

SEC source: 0001898490-26-000002 · form4-02252026_120208.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 263,766

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2026 Filed Feb 25, 2026 00:43 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 74,975 $19.66 $1,474,008.50
Disclosure

SEC source: 0001302443-26-000002 · form4-02252026_120248.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,576,094

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2026 Filed Feb 25, 2026 00:40 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 20,672 $19.66 $406,411.52
Disclosure

SEC source: 0001961289-26-000002 · form4-02252026_120248.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,123

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
December 03, 2025 Filed Dec 5, 2025 23:02 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 15,534 $18.75 $291,251.63
Disclosure

SEC source: 0001898490-25-000008 · form4-12052025_111222.xml · nonDerivative · entry 3

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 277,695

F1 · price: This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 03, 2025 Filed Dec 5, 2025 23:02 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 7,766 $18.75 $145,618.71
Disclosure

SEC source: 0001898490-25-000008 · form4-12052025_111222.xml · nonDerivative · entry 2

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 293,229

F1 · price: This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 03, 2025 Filed Dec 5, 2025 23:02 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 7,767 $18.75 $145,630.47
Disclosure

SEC source: 0001898490-25-000008 · form4-12052025_111222.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 300,995

F1 · price: This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 26, 2025 Filed Dec 2, 2025 00:02 UTC
BROSHY ERANDirector
Exercise / conversionShare Option (Right to Buy) · Derivative 14,000 $10.15 Strike: $10.15 $142,100.00
Disclosure

SEC source: 0001256230-25-000009 · form4-12022025_121248.xml · derivative · entry 3

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 81,749

Underlying: Ordinary Shares · 14,000 shares

Expires 2032-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This Share Option was fully vested and exercisable (having vested as to 1/12th of the shares subject to the option upon completion of each continuous month of service following the original grant date and any remaining unvested shares vesting on the date of the next annual meeting of the company's shareholders provided continuous service through such date).

F4 · balance_after: Reflects solely exercisable, vested Share Options following reported transaction.

Read SEC document
November 26, 2025 Filed Dec 2, 2025 00:02 UTC
BROSHY ERANDirector
SaleOrdinary Shares 15,501 $20.00 $310,020.00
Disclosure

SEC source: 0001256230-25-000009 · form4-12022025_121248.xml · nonDerivative · entry 2

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,703

F2 · price: The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024.

Read SEC document
November 26, 2025 Filed Dec 2, 2025 00:02 UTC
BROSHY ERANDirector
SaleOrdinary Shares 14,000 $20.00 $280,000.00
Disclosure

SEC source: 0001256230-25-000009 · form4-12022025_121248.xml · nonDerivative · entry 1

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,204

F1 · price: The reporting person exercised stock options to acquire 14,000 Ordinary Shares and sold all such shares on the same day in a broker-assisted transaction. No shares were withheld for taxes. The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024.

Read SEC document
November 20, 2025 Filed Nov 22, 2025 00:10 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 56,817 $17.90 $1,017,024.30
Disclosure

SEC source: 0001302443-25-000008 · form4-11222025_121129.xml · nonDerivative · entry 3

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,651,069

F3 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 20, 2025 Filed Nov 24, 2025 23:15 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
Tax withholdingOrdinary Shares 6,989 $17.90 $125,103.10
Disclosure

SEC source: 0002012524-25-000006 · form4-11242025_111102.xml · nonDerivative · entry 1

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,012

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 20, 2025 Filed Nov 24, 2025 23:13 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
Tax withholdingOrdinary Shares 19,024 $17.90 $340,529.60
Disclosure

SEC source: 0001966698-25-000006 · form4-11242025_111100.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 355,282

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 20, 2025 Filed Nov 24, 2025 23:11 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
Tax withholdingOrdinary Shares 9,060 $17.90 $162,174.00
Disclosure

SEC source: 0001898490-25-000006 · form4-11242025_111109.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 308,762

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 20, 2025 Filed Nov 24, 2025 23:16 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 18,627 $17.90 $333,423.30
Disclosure

SEC source: 0001961289-25-000006 · form4-11242025_111155.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,795

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 19, 2025 Filed Nov 22, 2025 00:10 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GiftOrdinary Shares 9,900 $0.00 $0.00
Disclosure

SEC source: 0001302443-25-000008 · form4-11222025_121129.xml · nonDerivative · entry 2

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Indirect · As Custodian

Disclosed balance after: 23,400

F1 · shares: Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.

F2 · ownership.nature: The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose.

Read SEC document
November 19, 2025 Filed Nov 22, 2025 00:10 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GiftOrdinary Shares 9,900 $0.00 $0.00
Disclosure

SEC source: 0001302443-25-000008 · form4-11222025_121129.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,707,886

F1 · shares: Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 02:00 UTC
BROSHY ERANDirector
Exercise / conversionShare Option (Right to Buy) · Derivative 14,000 $10.15 Strike: $10.15 $142,100.00
Disclosure

SEC source: 0001256230-25-000006 · form4-11142025_021112.xml · derivative · entry 4

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,878

Underlying: Ordinary Shares · 14,000 shares

Expires 2032-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option was fully vested and exercisable (having vested as to 1/12th of the shares subject to the option upon completion of each continuous month of service following the original grant date and any remaining unvested shares vesting on the date of the next annual meeting of the company's shareholders provided continuous service through such date).

Read SEC document
November 11, 2025 Filed Nov 14, 2025 02:00 UTC
BROSHY ERANDirector
SaleOrdinary Shares 14,000 $18.50 $259,000.00
Disclosure

SEC source: 0001256230-25-000006 · form4-11142025_021112.xml · nonDerivative · entry 3

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,204

F2 · price: The reporting person exercised stock options to acquire 14,000 Ordinary Shares and sold all such shares on the same day in a broker-assisted transaction. No shares were withheld for taxes. The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 02:00 UTC
BROSHY ERANDirector
SaleOrdinary Shares 15,500 $17.00 $263,500.00
Disclosure

SEC source: 0001256230-25-000006 · form4-11142025_021112.xml · nonDerivative · entry 2

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,204

F1 · price: The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 02:00 UTC
BROSHY ERANDirector
SaleOrdinary Shares 29,500 $18.50 $545,750.00
Disclosure

SEC source: 0001256230-25-000006 · form4-11142025_021112.xml · nonDerivative · entry 1

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,704

F1 · price: The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 11:00 UTC Amendment
BROSHY ERANDirector
Exercise / conversionShare Option (Right to Buy) · Derivative 14,000 $10.15 Strike: $10.15 $142,100.00
Disclosure

SEC source: 0001256230-25-000007 · form4a-11142025_061102.xml · derivative · entry 4

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,878

Underlying: Ordinary Shares · 14,000 shares

Expires 2032-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option was fully vested and exercisable (having vested as to 1/12th of the shares subject to the option upon completion of each continuous month of service following the original grant date and any remaining unvested shares vesting on the date of the next annual meeting of the company's shareholders provided continuous service through such date).

Read SEC document
November 11, 2025 Filed Nov 14, 2025 11:00 UTC Amendment
BROSHY ERANDirector
SaleOrdinary Shares 14,000 $18.50 $259,000.00
Disclosure

SEC source: 0001256230-25-000007 · form4a-11142025_061102.xml · nonDerivative · entry 3

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,204

F2 · price: The reporting person exercised stock options to acquire 14,000 Ordinary Shares and sold all such shares on the same day in a broker-assisted transaction. No shares were withheld for taxes. The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 11:00 UTC Amendment
BROSHY ERANDirector
SaleOrdinary Shares 15,500 $17.00 $263,500.00
Disclosure

SEC source: 0001256230-25-000007 · form4a-11142025_061102.xml · nonDerivative · entry 2

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,204

F1 · price: The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 11:00 UTC Amendment
BROSHY ERANDirector
SaleOrdinary Shares 15,500 $18.50 $286,750.00
Disclosure

SEC source: 0001256230-25-000007 · form4a-11142025_061102.xml · nonDerivative · entry 1

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,704

F1 · price: The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024.

Read SEC document
August 20, 2025 Filed Aug 22, 2025 22:05 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
Tax withholdingOrdinary Shares 6,989 $13.39 $93,582.71
Disclosure

SEC source: 0001415889-25-022799 · form4-08222025_100811.xml · nonDerivative · entry 1

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 208,001

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
August 20, 2025 Filed Aug 22, 2025 22:03 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
Tax withholdingOrdinary Shares 9,762 $13.39 $130,713.18
Disclosure

SEC source: 0001415889-25-022797 · form4-08222025_100841.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,306

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
August 20, 2025 Filed Aug 22, 2025 22:01 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
Tax withholdingOrdinary Shares 9,096 $13.39 $121,795.44
Disclosure

SEC source: 0001415889-25-022794 · form4-08222025_100855.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,822

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
August 20, 2025 Filed Aug 22, 2025 22:09 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 15,394 $13.39 $206,125.66
Disclosure

SEC source: 0001415889-25-022803 · form4-08222025_100815.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,717,786

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
August 20, 2025 Filed Aug 22, 2025 22:07 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 9,368 $13.39 $125,437.52
Disclosure

SEC source: 0001415889-25-022801 · form4-08222025_100803.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 355,422

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
July 14, 2025 Filed Jul 16, 2025 22:01 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 4,000 $11.39 $45,551.60
Disclosure

SEC source: 0001415889-25-019869 · form4-07162025_100710.xml · nonDerivative · entry 3

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 326,918

F2 · price: This transaction was executed in multiple trades at prices from $11.24 to $11.46 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 14, 2025 Filed Jul 16, 2025 22:01 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 5,318 $11.39 $60,548.09
Disclosure

SEC source: 0001415889-25-019869 · form4-07162025_100710.xml · nonDerivative · entry 2

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 330,918

F2 · price: This transaction was executed in multiple trades at prices from $11.24 to $11.46 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 14, 2025 Filed Jul 16, 2025 22:01 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 682 $11.39 $7,769.82
Disclosure

SEC source: 0001415889-25-019869 · form4-07162025_100710.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 336,236

F1 · price: This transaction was executed in multiple trades at prices from $11.24 to $11.465 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 22:06 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GiftOrdinary Shares 20,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-018221 · form4-06252025_100657.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,733,180

F1 · shares: Bona Fide Gift. No compensation was given to the donor for the gifting of shares.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 22:16 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GiftOrdinary Shares 9,600 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017585 · form4-06172025_100629.xml · nonDerivative · entry 2

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Indirect · As Custodian

Disclosed balance after: 13,500

F1 · shares: Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.

F2 · ownership.nature: The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 22:16 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GiftOrdinary Shares 9,600 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017585 · form4-06172025_100629.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,753,180

F1 · shares: Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 22:04 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 24,000 $11.00 $264,000.00
Disclosure

SEC source: 0001415889-25-015642 · form4-06042025_100617.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 336,918

Read SEC document
May 20, 2025 Filed May 21, 2025 23:22 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
Tax withholdingOrdinary Shares 9,701 $9.45 $91,674.45
Disclosure

SEC source: 0001415889-25-014025 · form4-05212025_110558.xml · nonDerivative · entry 2

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,990

F2 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
May 20, 2025 Filed May 22, 2025 22:41 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
Tax withholdingOrdinary Shares 9,743 $9.45 $92,071.35
Disclosure

SEC source: 0001415889-25-014259 · form4-05222025_100517.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 384,068

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
May 20, 2025 Filed May 22, 2025 22:39 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
Tax withholdingOrdinary Shares 9,120 $9.45 $86,184.00
Disclosure

SEC source: 0001415889-25-014257 · form4-05222025_100521.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 360,918

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
May 20, 2025 Filed May 22, 2025 22:44 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 15,364 $9.45 $145,189.80
Disclosure

SEC source: 0001415889-25-014263 · form4-05222025_100552.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,762,780

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.